BioSpace News Archive

Drug Development

Kala Pharma Sinks on Mixed Data From Two Phase III Dry Eye Disease Studies

Kala Pharma released mostly positive topline results from two Phase III clinical trials for KPI-121 in patients with dry eye disease.

January 5, 2018
·
2 min read
·
Mark Terry
Business

Teva, Union Reach Deal on HQ Layoffs for Administrative Staff

The agreement covers employees who agree to leave voluntarily.

January 5, 2018
·
1 min read
BioCapital

3 Biotechs That Could Outperform in 2018

A look at why investors should stock up on Amgen, Celldex Therapeutics, and Novavax soon.

January 5, 2018
·
1 min read
Bio NC

Bridging Clinical Research & Clinical Health Care: How to Improve Patient Centricity

For multiple perspectives on addressing this challenge, three respected individuals involved with the effort to bridge clinical research and clinical health care share their views.

January 5, 2018
·
4 min read
·
Joan Chambers and Naomi Fujimoto, BioSpace Contributors
Job Trends

Medtronic to Build New Facility in Memphis

Medtronic’s building permit for the new facility is valued at $900,000, with the listed architect as Thoda & Associates.

January 5, 2018
·
1 min read
Genostics Invests $13.5M in UK’s Oncimmune for China Rights to Lung Cancer Test

Genostics will acquire China rights to Oncimmune’s blood-based cancer testing platform in return for a $13.5M investment into the UK-based company’s shares.

January 5, 2018
·
1 min read
Business

Ex-Genentechers’ Denali Scores $1B+ Alzheimer’s Deal With Takeda

Takeda CEO Christophe Weber is sticking to his game plan of actively hunting deals that will expand its global presence and create a stronger international profile.

January 5, 2018
·
2 min read
·
Alex Keown
Business

KBP Biosciences Lands $76M, an Ex-GlaxoSmithKline Exec as Its New CEO and a HQ Move to Philly

The financing was co-led by Advantech Capital and SDIC Venture Capital.

January 5, 2018
·
2 min read
·
Mark Terry
Drug-Delivery Tech Developer AMW Scores $30M

The company’s newly-acquired funds will specifically support a new R&D facility located in Bavaria.

January 5, 2018
·
1 min read
Deals

Busy Takeda Takes Out Tigenix in $630M Deal

Shares of TiGenix shot up more than 72 percent in pre-market trading after the deal was announced.

January 5, 2018
·
2 min read
·
Alex Keown